Interestingly, the effect of mutations on CTCF binding was found to be non-uniform, for instance different mutations in its zinc finger 3 domain led to selective inhibition of binding to different targets suggesting that there is a tumor-specific change of function rather than loss of function41. The gene discussed is CTCF; the disease is neoplasm.